Neurofilament Light Protein Predicts Disease Progression in Idiopathic REM Sleep Behavior Disorder
Journal of Parkinson’s Disease · 2023
DOI: 10.3233/jpd-223519 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Parkinson’s Disease, 2023. Verfasst von Xuan Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Tianjin Medical University General Hospital Airport Site, Tianjin, China. Hauptthemen laut MEDLINE: REM Sleep Behavior Disorder, Parkinson Disease, Synucleinopathies. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Idiopathic rapid eye movement sleep behavior disorder (iRBD) is increasingly recognized as a manifestation preceding the α-synucleinopathies like Parkinson’s disease (PD). Neurofilament light chain (NfL) have been reported to be higher in synucleinopathies as a sign of neurodegeneration.
Objective
To evaluate whether plasma NfL is valuable in reflecting cognitive and motor status in iRBD and PD with a premorbid history of RBD (PDRBD), and predicting disease progression in iRBD.
Methods
Thirty-one patients with iRBD, 30 with PDRBD, and 18 healthy controls were included in the cross-sectional and prospective study. Another cohort from the Parkinson’s Progression Markers Initiative (PPMI) dataset was enrolled for verification analysis. All patients received evaluations of cognitive, motor, and autonomic function by a battery of clinical tests at baseline and follow-up. Blood NfL was measured by the Quanterix Simoa HD-1.
Results
In our cohort, 26 patients with iRBD completed the follow-up evaluations, among whom eight (30.8%) patients displayed phenoconversion. Baseline plasma NfL cutoff value of 22.93 pg/mL performed best in distinguishing the iRBD converters from non-converters (sensitivity: 75.0%, specificity: 83.3%, area under the curve: 0.84). Cognitive and motor function were significantly correlated with NfL levels in PDRBD (correlation coefficients: –0.379, 0.399; respectively). Higher baseline NfL levels in iRBD were significantly associated with higher risks for cognitive, motor, autonomic function progression, and phenoconversion at follow-up (hazard ratios: 1.069, 1.065, 1.170, 1.065; respectively). The findings were supported by the PPMI dataset.
Conclusion
Plasma NfL is valuable in reflecting disease severity of PDRBD and predicting disease progression and phenoconversion in iRBD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Tianjin Medical University General Hospital Airport Site, Tianjin, China.
- Department of Neurology, Tianjin Medical University General Hospital, Tianjin, China.
- Tianjin Neurological Institute, Tianjin Medical University General Hospital, Tianjin, China.
Zitieren
APA
Zhang, X., Ma, L., Liang, D., Song, B., Chen, J., Huang, Y., Xu, L., Zhao, P., Wu, W., Zhang, N., & Xue, R. (2023). Neurofilament Light Protein Predicts Disease Progression in Idiopathic REM Sleep Behavior Disorder. Journal of Parkinson’s Disease. https://doi.org/10.3233/jpd-223519
Vancouver
Zhang X, Ma L, Liang D, Song B, Chen J, Huang Y, et al. Neurofilament Light Protein Predicts Disease Progression in Idiopathic REM Sleep Behavior Disorder. Journal of Parkinson’s Disease. 2023. doi:10.3233/jpd-223519
BibTeX
@article{Zhang2023,
author = {Zhang, Xuan and Ma, Li and Liang, Danqi and Song, Bingxin and Chen, Jingshan and Huang, Yaqin and Xu, Lin and Zhao, Peng and Wu, Wei and Zhang, Nan and Xue, Rong},
title = {Neurofilament Light Protein Predicts Disease Progression in Idiopathic REM Sleep Behavior Disorder},
journal = {Journal of Parkinson’s Disease},
year = {2023},
doi = {10.3233/jpd-223519}
}
EUVIMED